Artelo Biosciences, Inc. (ARTL)
Last updated: 2026-10-24 14:41:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Artelo Biosciences, Inc. (ARTL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.57, with a market capitalization of $1.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.48 to $179.19. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.40M | |
$2.64 | |
$351,280.80 | |
$2.48 | |
$2.55 | |
25.89K | |
489.05K | |
-- | |
$179.19 | |
$2.48 | |
-- | |
-- |
Artelo Biosciences, Inc. (ARTL) Latest Closing Stock Price
Artelo Biosciences, Inc. (ARTL) last closed at $2.55 as of 2026-10-23 23:57:00, unchanged from the previous close of $2.55.
During the latest regular trading session, ARTL traded between $2.48 and $351,280.80, with a volume of 25.89K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Artelo Biosciences, Inc. (ARTL) 7-Day Stock Price Change
Over the past seven days, Artelo Biosciences, Inc. (ARTL) moved from $2.74 to $2.57, representing a decline of 6.20% ($0.17).
The stock traded between $2.48 and $2.90 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 18.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ARTL 52-Week Price Position
Position in Range: 0.1%
ARTL is currently trading at $2.57, placing it 0.1% of the way from its 52-week low of $2.48 to its 52-week high of $179.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Artelo Biosciences, Inc. (ARTL)?
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Artelo Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 7 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Artelo Biosciences, Inc. (ARTL) Stock on MEXC
Eligible investors can buy real shares of Artelo Biosciences, Inc. (ARTL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Artelo Biosciences, Inc. (ARTL) stock price today?
2.Is ARTL stock going up or down today?
3.What is ARTL pre-market price?
4.What is ARTL after-hours price?
5.Is ARTL stock trading now?
6.Where does ARTL sit relative to its 52-week high and low?
7.What sector is Artelo Biosciences, Inc. in?
8.What is Artelo Biosciences, Inc.'s market capitalization and where is it listed?
9.How is ARTL valued in terms of P/E ratio and EPS?
10.Does Artelo Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ARTL Stock Calculator
Estimate the value between ARTL shares and USD.
ARTL Shares to USD
1.00 ARTL shares = 2.57 USD
Calculations are estimates based on the latest available price and are for reference only.


